INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2012
Total net assets |
£132.4m |
NAV per share |
238.8p |
Share price |
213.0p |
Total value of unquoted investments |
£20.9m |
Total number of portfolio companies |
67 |
Cash |
3% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
18.17% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Celgene Alexion |
7.2 6.6 5.0 |
Aptiv |
4.2 |
Onyx |
3.7 |
Gilead |
3.4 |
Pharmaxis |
3.0 |
Insulet |
3.0 |
Life Technologies Jazz |
2.9 2.7 |
|
----------- |
Total |
41.7 |
Geographical Allocation |
% |
United States & Canada |
86 |
Europe |
8 |
Australia |
3 |
Cash |
3 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
81 |
Unquoted |
16 |
Cash |
3 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
26 OCTOBER 2012